Projects

Efficacy and safety of DRL-1801 (CAR-T cell therapy) in Relapsed Refractory Multiple Myeloma (SWASTH): Phase I/II

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - 2028

Project Lead

Dr.Hari Menon

Authors

Dr.Hari Menon, Dr.Ganesha , Dr.Annie K Baa

Project Status

ongoing

Project Type

St John’s Medical College Research Society